Gavin McDonnell

2.5k total citations
42 papers, 786 citations indexed

About

Gavin McDonnell is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Gavin McDonnell has authored 42 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 12 papers in Immunology and 8 papers in Neurology. Recurrent topics in Gavin McDonnell's work include Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (8 papers) and Immunotherapy and Immune Responses (6 papers). Gavin McDonnell is often cited by papers focused on Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (8 papers) and Immunotherapy and Immune Responses (6 papers). Gavin McDonnell collaborates with scholars based in United Kingdom, Ireland and United States. Gavin McDonnell's co-authors include Stanley Hawkins, Colin A. Graham, Aidan Droogan, Orla Gray, S A McMillan, Raeburn B Forbes, JOHN DOUGLAS, Koen Vandenbroeck, Derek Middleton and Shirley Heggarty and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Gavin McDonnell

41 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gavin McDonnell United Kingdom 17 469 295 160 153 138 42 786
Lisa Costelloe Ireland 11 483 1.0× 485 1.6× 137 0.9× 191 1.2× 134 1.0× 15 1.0k
Maria Rosaria Tola Italy 19 326 0.7× 326 1.1× 93 0.6× 150 1.0× 266 1.9× 29 975
Becky Parks United States 17 680 1.4× 319 1.1× 167 1.0× 201 1.3× 348 2.5× 31 1.2k
George J. Hutton United States 14 619 1.3× 201 0.7× 133 0.8× 188 1.2× 213 1.5× 46 865
Norman J. Kachuck United States 9 707 1.5× 234 0.8× 220 1.4× 147 1.0× 343 2.5× 14 898
T. Arbizu Spain 15 563 1.2× 154 0.5× 165 1.0× 161 1.1× 216 1.6× 28 745
Cristina Ramo‐Tello Spain 19 408 0.9× 530 1.8× 119 0.7× 146 1.0× 197 1.4× 52 1.0k
Begoña Oliver‐Martos Spain 17 262 0.6× 287 1.0× 105 0.7× 188 1.2× 251 1.8× 63 959
R. Philip Kinkel United States 11 529 1.1× 155 0.5× 168 1.1× 355 2.3× 257 1.9× 15 850
S V Ramagopalan United Kingdom 7 507 1.1× 155 0.5× 140 0.9× 126 0.8× 159 1.2× 10 608

Countries citing papers authored by Gavin McDonnell

Since Specialization
Citations

This map shows the geographic impact of Gavin McDonnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin McDonnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin McDonnell more than expected).

Fields of papers citing papers by Gavin McDonnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin McDonnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin McDonnell. The network helps show where Gavin McDonnell may publish in the future.

Co-authorship network of co-authors of Gavin McDonnell

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin McDonnell. A scholar is included among the top collaborators of Gavin McDonnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin McDonnell. Gavin McDonnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Young, Carolyn, David Rog, Basil Sharrack, et al.. (2025). Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories. Journal of the Neurological Sciences. 470. 123409–123409. 2 indexed citations
2.
Csincsik, Lajos, Luping Wang, Denise Fitzgerald, et al.. (2023). Reduced Cone Density Is Associated with Multiple Sclerosis. SHILAP Revista de lepidopterología. 3(3). 100308–100308. 6 indexed citations
3.
Naughton, Michelle, et al.. (2022). A Review of Compartmentalised Inflammation and Tertiary Lymphoid Structures in the Pathophysiology of Multiple Sclerosis. Biomedicines. 10(10). 2604–2604. 15 indexed citations
4.
Naughton, Michelle, Andrew Young, John Falconer, et al.. (2020). CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis. Journal of Neuroinflammation. 17(1). 349–349. 12 indexed citations
5.
Middleton, Rod, Arron Lacey, Owen Pearson, et al.. (2019). 030 Automating clinical audit in neurology. Journal of Neurology Neurosurgery & Psychiatry. 90(12). A18.1–A18. 1 indexed citations
6.
Bevan, Ryan J., Lewis M. Watkins, Mark I. Rees, et al.. (2018). Meningeal inflammation and cortical demyelination in acute multiple sclerosis. Annals of Neurology. 84(6). 829–842. 102 indexed citations
7.
Cameron, Elaine, David Rog, Gavin McDonnell, et al.. (2018). Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview study. Multiple Sclerosis and Related Disorders. 27. 378–382. 17 indexed citations
8.
Gray, Orla, et al.. (2010). Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma. BMJ Case Reports. 2010. bcr0120091486–bcr0120091486. 18 indexed citations
9.
Heggarty, Shirley, Vijayaprakash Suppiah, Jonathan A. Silversides, et al.. (2007). CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland. Journal of Neuroimmunology. 187(1-2). 187–191. 26 indexed citations
10.
Heggarty, Shirley, et al.. (2006). Mapping candidate non-MHC susceptibility regions to multiple sclerosis. Genes and Immunity. 7(6). 494–502. 9 indexed citations
11.
Cunningham, Stephen, Catherine O’Doherty, C. C. Patterson, et al.. (2006). The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis. Journal of Neuroimmunology. 183(1-2). 208–213. 7 indexed citations
12.
Suppiah, Vijayaprakash, An Goris, Iraide Alloza, et al.. (2005). Polymorphisms in the interleukin‐4 and IL‐4 receptor genes and multiple sclerosis: a study in Spanish‐Basque, Northern Irish and Belgian populations. International Journal of Immunogenetics. 32(6). 383–388. 29 indexed citations
13.
Cunningham, Stephen, Colin A. Graham, Michael Hutchinson, et al.. (2005). Pharmacogenomics of responsiveness to interferon IFN-β treatment in multiple sclerosis: A genetic screen of 100 type I interferon-inducible genes. Clinical Pharmacology & Therapeutics. 78(6). 635–635. 58 indexed citations
14.
Cunningham, Steve, CC Patterson, Gavin McDonnell, Stanley Hawkins, & Koen Vandenbroeck. (2005). Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis. Genes and Immunity. 6(3). 265–270. 11 indexed citations
15.
Heggarty, Shirley, Stephen Sawcer, Stanley Hawkins, et al.. (2003). A genome wide scan for association with multiple sclerosis in a N. Irish case control population. Journal of Neuroimmunology. 143(1-2). 93–96. 16 indexed citations
16.
Crockard, A. D., et al.. (2001). Serum and cerebrospinal fluid soluble Fas levels in clinical subgroups of multiple sclerosis. Immunology Letters. 78(3). 183–187. 12 indexed citations
17.
McDonnell, Gavin, C W Kirk, Stanley Hawkins, & Colin A. Graham. (2000). An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. Journal of the Neurological Sciences. 176(1). 4–12. 25 indexed citations
18.
McMillan, S A, Gavin McDonnell, Jane Douglas, & Stanley Hawkins. (2000). Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis. Acta Neurologica Scandinavica. 101(4). 239–243. 12 indexed citations
19.
McDonnell, Gavin, S A McMillan, JOHN DOUGLAS, Aidan Droogan, & Stanley Hawkins. (1999). Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease. Journal of Neurology. 246(2). 87–92. 46 indexed citations
20.
Crockard, A. D., et al.. (1999). CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients:. Journal of the Neurological Sciences. 167(2). 79–89. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Costelloe Breakdown of academic impact, for papers by Maria Rosaria Tola Breakdown of academic impact, for papers by Becky Parks Breakdown of academic impact, for papers by George J. Hutton Breakdown of academic impact, for papers by Norman J. Kachuck Breakdown of academic impact, for papers by T. Arbizu Breakdown of academic impact, for papers by Cristina Ramo‐Tello Breakdown of academic impact, for papers by Begoña Oliver‐Martos Breakdown of academic impact, for papers by R. Philip Kinkel Breakdown of academic impact, for papers by S V Ramagopalan
Rankless by CCL
2026